Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tisdale

Showing results (21-30 of 307) with videos related to

Pageof 31
Sort By:
Chemico-Biological Interactions|April 1, 1980
The effect of cyclic nucleotides on DNA polymerase, thymidylate synthetase, thymidine kinase and deoxynucleoside levels of Waler carcinomaM J Tisdale
Traffic (Copenhagen, Denmark)|February 24, 2001
Rab2 requires PKC iota/lambda to recruit beta-COP for vesicle formationE J Tisdale
Current Opinion in Clinical Nutrition and Metabolic Care|November 24, 1999
New cachexic factorsM J Tisdale
Nutrition (Burbank, Los Angeles County, Calif.)|January 1, 1997
Cancer cachexia: metabolic alterations and clinical manifestationsM J Tisdale
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1993
Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory proteinM J Tisdale
Carbohydrate Research|August 1, 1971
1,2-anhydro-6-O-methanesulphonyl-D-mannitolM J Tisdale
Biochemical and Biophysical Research Communications|February 17, 1975
Inhibition of cyclic adenosine 3',5'-monophosphate phosphodiesterase from Walker carcinoma by ascorbic and dehydroascorbic acidsM J Tisdale
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 25, 2006
Clinical anticachexia treatmentsMichael J Tisdale
Current Opinion in Supportive and Palliative Care|August 8, 2008
Is there a common mechanism linking muscle wasting in various disease types?Michael J Tisdale
Physiological Reviews|April 4, 2009
Mechanisms of cancer cachexiaMichael J Tisdale
Pageof 31

Showing results (21-30 of 307) with videos related to

Sort By:
Pageof 31
Chemico-Biological Interactions|April 1, 1980
The effect of cyclic nucleotides on DNA polymerase, thymidylate synthetase, thymidine kinase and deoxynucleoside levels of Waler carcinomaM J Tisdale
Traffic (Copenhagen, Denmark)|February 24, 2001
Rab2 requires PKC iota/lambda to recruit beta-COP for vesicle formationE J Tisdale
Current Opinion in Clinical Nutrition and Metabolic Care|November 24, 1999
New cachexic factorsM J Tisdale
Nutrition (Burbank, Los Angeles County, Calif.)|January 1, 1997
Cancer cachexia: metabolic alterations and clinical manifestationsM J Tisdale
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1993
Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory proteinM J Tisdale
Carbohydrate Research|August 1, 1971
1,2-anhydro-6-O-methanesulphonyl-D-mannitolM J Tisdale
Biochemical and Biophysical Research Communications|February 17, 1975
Inhibition of cyclic adenosine 3',5'-monophosphate phosphodiesterase from Walker carcinoma by ascorbic and dehydroascorbic acidsM J Tisdale
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 25, 2006
Clinical anticachexia treatmentsMichael J Tisdale
Current Opinion in Supportive and Palliative Care|August 8, 2008
Is there a common mechanism linking muscle wasting in various disease types?Michael J Tisdale
Physiological Reviews|April 4, 2009
Mechanisms of cancer cachexiaMichael J Tisdale
Pageof 31